COMMUNIQUÉS West-GlobeNewswire

CrazyBulk “Legal Steroid Alternatives” for Muscle Growth: A Safer Shift in Bodybuilding and Performance Nutrition 2025
19/06/2025
New York City, NY, June 19, 2025 (GLOBE NEWSWIRE) -- As traditional anabolic steroids fall further out of favor due to health and legal concerns, the CrazyBulk line of natural performance supplements emerges as a widely [...]
Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
19/06/2025
MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases [...]
VitalHub Completes Acquisition of Induction
19/06/2025
TORONTO, June 19, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) announced that it has completed the cash acquisition of Induction Healthcare Group PLC (“Induction”) by [...]
Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
19/06/2025
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas [...]
dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
19/06/2025
Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapies DURHAM, N.C. and WEST VALLEY CITY, Utah, June 19, 2025 (GLOBE NEWSWIRE) -- dGenThera, Inc., a biotechnology [...]
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/06/2025
FRIENDSWOOD, Texas, June 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2025, the [...]
Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant Congress
19/06/2025
PRESS RELEASE Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant [...]
Cannara Biotech organise une webdiffusion pour les investisseurs le 25 juin 2025
19/06/2025
MONTRÉAL, 19 juin 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara » , « la Société » , « nous » ou « notre » ) ( TSXV : LOVE ) ( OTCQB : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis [...]
Cannara Biotech to Host Investor Webcast on June 25th, 2025
19/06/2025
MONTREAL, June 19, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment
19/06/2025
New studies confirm the clear benefit of early acute treatment, the consistent effectiveness of REN over years, and its clinical benefits in migraine both with and without aura BRIDGEWATER, N.J. and NETANYA, Israel, [...]
Commure Raises $200 Million in Growth Financing from General Catalyst’s CVF to Accelerate AI-Powered RCM Platform
19/06/2025
SAN FRANCISCO, June 19, 2025 (GLOBE NEWSWIRE) -- Commure , the fast-growing enterprise AI healthcare technology company powering next-generation infrastructure for providers, today announced it has secured $200 million [...]
Symbiotic.blue Launches to Combine Oxford and Cambridge Scientific Brain Power with Bioentrepreneurial Leadership to Reinvent AI Drug Discovery
19/06/2025
LONDON, June 19, 2025 (GLOBE NEWSWIRE) -- Symbiotic.blue, the UK’s newest Techbio company has launched to innovate a next-generation artificial intelligence-driven drug discovery (AIDD) platform by combining the power [...]
Verano Announces Exclusive Partnership with Award-Winning Arizona Cannabis Operator Grow Sciences to Bring its Best-In-Class Products to Illinois
19/06/2025
Grow Sciences flower, pre-rolls, solventless extracts, vaporizers and edibles will initially be sold exclusively at Zen Leaf dispensaries in the Illinois market CHICAGO, June 19, 2025 (GLOBE NEWSWIRE) -- Verano Holdings [...]
Catholic Health Teams Up with Olympic Gold Medalist Katie Ledecky to Help Patients Optimize Their Health
19/06/2025
As Health & Wellness Ambassador at Catholic Health, Ledecky channels her Olympic mindset to educate Long Islanders ROCKVILLE CENTRE, N.Y., June 19, 2025 (GLOBE NEWSWIRE) -- Catholic Health is teaming up with nine- [...]
Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
19/06/2025
Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior [...]
VIRBAC: Paul Martingell nommé directeur général du groupe Virbac au 1er septembre 2025
19/06/2025
Virbac annonce la nomination de Paul Martingell en tant que directeur général du groupe Virbac à compter du 1 er septembre 2025. Paul Martingell, 45 ans, est un leader reconnu qui a démontré sa capacité à fédérer des [...]
VIRBAC: Paul Martingell is appointed chief executive officer of Virbac, effective September 1, 2025
19/06/2025
Virbac announces the appointment of Paul Martingell as the chief executive officer of the Virbac group, effective September 1, 2025. Paul Martingell, 45, is recognized as a leader who has demonstrated his ability to [...]
Major shareholder announcement
19/06/2025
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital attached to shares and [...]
CancerVax Nanoparticle Successfully Targets Cancer Cells While Sparing Non-cancerous Cells
19/06/2025
In-vitro lab results confirmed that the Company’s cell targeting nanoparticles successfully entered cancer cells and avoided non-cancerous cells Lehi, June 19, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah – June 19, 2025 – [...]

Pages